IRSF launches $1M fund to include males in Rett syndrome research
What's the deal? The International Rett Syndrome Foundation (IRSF)Dealroom has a profile for this one. Try Dealroom → has launched MR., the Males with Rett Fund, a $1 million effort dedicated to research that includes males with Rett syndrome. Families of the boys and men it serves hold governing oversight alongside IRSF scientific and regulatory expertise.
How it's funded: IRSF has committed the first $200,000 to an initial project aimed at closing scientific gaps that limit male inclusion in research and therapeutic development. The remaining $800,000 will come from community events and individual donors.
Why now? Rett syndrome was long described as a girls' disease, leaving many boys undiagnosed or misdiagnosed. The Male Rett Spectrum Study, led by Drs. Tim Benke and Talia Thompson of the University of Colorado School of MedicineDealroom has a profile for this one. Try Dealroom →, recently confirmed that boys have Rett, their experiences vary widely, and outdated assumptions have delayed diagnosis.
What's the endgame? Every MR. project must be fully male-inclusive; no project moves forward unless it advances understanding, access, or inclusion of boys and men with Rett. The fund adds dedicated money without redirecting resources from the broader Rett research agenda.
"No project moves forward unless it explicitly includes males with Rett syndrome," said Laura Hameed, chief executive officer of IRSF. "Every child who has Rett, whether male or female, deserves the same chance at a timely diagnosis, the right care, a fair place in clinical trials, and ultimately, access to treatments that can benefit them."
The data edge: IRSF holds the largest collection of male Rett registry data in the world, built partly through male-specific questions added to its Rett Syndrome Registry. That base gives the fund evidence to build on.
Mary and Richard Engel, who lost their son Henry to Rett syndrome and serve on the MR. Fund Advisory Board, said males "have largely been left out of clinical trials despite the urgent need for these interventions. This must change."
The signal: The $1 million is positioned as a starting point rather than a finish line — enough to fund a first wave of male-inclusive research and generate the evidence needed to attract larger investment down the line.
Read more: einpresswire.com
Image credit: International Rett Syndrome Foundation
